Literature DB >> 14623899

Nutrient-dependent and insulin-stimulated phosphorylation of insulin receptor substrate-1 on serine 302 correlates with increased insulin signaling.

Jodel Giraud1, Rebecca Leshan, Yong-Hee Lee, Morris F White.   

Abstract

Ser/Thr phosphorylation of insulin receptor substrate IRS-1 regulates insulin signaling, but the relevant phosphorylated residues and their potential functions during insulin-stimulated signal transduction are difficult to resolve. We used a sequence-specific polyclonal antibody directed against phosphorylated Ser(302) to study IRS-1-mediated signaling during insulin and insulin-like growth factor IGF-I stimulation. Insulin or IGF-I stimulated phosphorylation of Ser(302) in various cell backgrounds and in murine muscle. Wortmannin or rapamycin inhibited Ser(302) phosphorylation, and amino acids or glucose stimulated Ser(302) phosphorylation, suggesting a role for the mTOR cascade. The Ser(302) kinase associates with IRS-1 during immunoprecipitation, but its identity is unknown. The NH(2)-terminal c-Jun kinase did not phosphorylate Ser(302). Replacing Ser(302) with alanine significantly reduced insulin-stimulated tyrosine phosphorylation of IRS-1 and p85 binding and reduced insulin-stimulated phosphorylation of p70(S6K), ribosomal S6 protein, and 4E-BP1; however, this mutation had no effect on insulin-stimulated Akt or glycogen synthase kinase 3beta phosphorylation. Replacing Ser(302) with alanine reduced insulin/IGF-I-stimulated DNA synthesis. We conclude that Ser(302) phosphorylation integrates nutrient availability with insulin/IGF-I signaling to promote mitogenesis and cell growth.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14623899     DOI: 10.1074/jbc.M308631200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

Review 1.  Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction.

Authors:  Katsutaro Morino; Kitt Falk Petersen; Gerald I Shulman
Journal:  Diabetes       Date:  2006-12       Impact factor: 9.461

2.  Insulin and metabolic stress stimulate multisite serine/threonine phosphorylation of insulin receptor substrate 1 and inhibit tyrosine phosphorylation.

Authors:  Nancy J Hançer; Wei Qiu; Christine Cherella; Yedan Li; Kyle D Copps; Morris F White
Journal:  J Biol Chem       Date:  2014-03-20       Impact factor: 5.157

3.  Hyperinsulinemia induces insulin resistance in dorsal root ganglion neurons.

Authors:  Bhumsoo Kim; Lisa L McLean; Stephen S Philip; Eva L Feldman
Journal:  Endocrinology       Date:  2011-08-02       Impact factor: 4.736

4.  Turnover of the active fraction of IRS1 involves raptor-mTOR- and S6K1-dependent serine phosphorylation in cell culture models of tuberous sclerosis.

Authors:  O Jameel Shah; Tony Hunter
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

Review 5.  Central insulin and leptin-mediated autonomic control of glucose homeostasis.

Authors:  Joseph S Marino; Yong Xu; Jennifer W Hill
Journal:  Trends Endocrinol Metab       Date:  2011-04-12       Impact factor: 12.015

6.  Attenuated mTOR signaling and enhanced autophagy in adipocytes from obese patients with type 2 diabetes.

Authors:  Anita Ost; Kristoffer Svensson; Iida Ruishalme; Cecilia Brännmark; Niclas Franck; Hans Krook; Per Sandström; Preben Kjolhede; Peter Strålfors
Journal:  Mol Med       Date:  2010-03-26       Impact factor: 6.354

7.  S6K directly phosphorylates IRS-1 on Ser-270 to promote insulin resistance in response to TNF-(alpha) signaling through IKK2.

Authors:  Jin Zhang; Zhanguo Gao; Jun Yin; Michael J Quon; Jianping Ye
Journal:  J Biol Chem       Date:  2008-10-24       Impact factor: 5.157

8.  Protein kinase C-zeta phosphorylates insulin receptor substrate-1, -3, and -4 but not -2: isoform specific determinants of specificity in insulin signaling.

Authors:  Sihoon Lee; Edward G Lynn; Jeong-A Kim; Michael J Quon
Journal:  Endocrinology       Date:  2008-01-17       Impact factor: 4.736

9.  Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue.

Authors:  Vanessa P Houde; Sophie Brûlé; William T Festuccia; Pierre-Gilles Blanchard; Kerstin Bellmann; Yves Deshaies; André Marette
Journal:  Diabetes       Date:  2010-03-18       Impact factor: 9.461

10.  Beta-amyloid monomers are neuroprotective.

Authors:  Maria Laura Giuffrida; Filippo Caraci; Bruno Pignataro; Sebastiano Cataldo; Paolo De Bona; Valeria Bruno; Gemma Molinaro; Giuseppe Pappalardo; Angela Messina; Angelo Palmigiano; Domenico Garozzo; Ferdinando Nicoletti; Enrico Rizzarelli; Agata Copani
Journal:  J Neurosci       Date:  2009-08-26       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.